ENTITY
Global Cord Blood

Global Cord Blood (CO US)

21
Analysis
Health Care • United States
Global Cord Blood Corporation operates as a life sciences enterprise. The Company provides collection of umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing, and stem cell storage services. Global Cord Blood also operates as cord blood banking operator. Global Cord Blood serves customers in China.
more
•26 Nov 2021 23:30

Global Cord Blood (CO US): Overhangs Persist; Weak Q2 Results Adds to Woe

Global Cord reported muted Q2 results with revenue and new subscribers sign-ups remaining flat sequentially, representing slower recovery. Shares...

Logo
651 Views
Share
bullish•SOHO China
•30 Jun 2021 08:21

(Mostly) Asia M&A: June 2021 Roundup

The average premium for the new deals announced (or first discussed) in June was ~41%, with a year-to-date average of ~32% (89 deals & total dal...

Logo
493 Views
Share
bullish•Chong Hing Bank
•31 May 2021 13:47

(Mostly) Asia M&A: May 2021 Roundup

The average premium for the new deals announced (or first discussed) in May was ~41%, with a year-to-date average of ~31% (78 deals).

Logo
545 Views
Share
•30 Apr 2021 08:00

(Mostly) Asia M&A: April 2021 Roundup

The average premium for the new deals announced (or first discussed) in April was ~13%, with a year-to-date average of ~30% (66 deals).

Logo
568 Views
Share
•31 Mar 2021 11:29

(Mostly) Asia M&A: March 2021 Roundup

The average premium for the new deals announced (or first discussed) in March was ~31%, with a year-to-date average of ~31% (57 deals).

Logo
510 Views
Share
x